zabofloxacin and Gonorrhea

zabofloxacin has been researched along with Gonorrhea* in 1 studies

Other Studies

1 other study(ies) available for zabofloxacin and Gonorrhea

Article	Year
Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:1 Zabofloxacin, a new fluoroquinolone compound (DW-224a), was tested by reference agar dilution methods against 35 strains of multiresistant Neisseria gonorrhoeae. The potency of zabofloxacin (MIC(50), 0.016 microg/mL) was generally comparable with azithromycin but 8-fold superior to ciprofloxacin. This novel naphthyridine should be explored as an alternative therapy for quinolone-nonsusceptible gonorrhea and Chlamydia trachomatis infections. Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quinolones	2008

Article

Year

Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.

Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:1

Zabofloxacin, a new fluoroquinolone compound (DW-224a), was tested by reference agar dilution methods against 35 strains of multiresistant Neisseria gonorrhoeae. The potency of zabofloxacin (MIC(50), 0.016 microg/mL) was generally comparable with azithromycin but 8-fold superior to ciprofloxacin. This novel naphthyridine should be explored as an alternative therapy for quinolone-nonsusceptible gonorrhea and Chlamydia trachomatis infections.

Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quinolones

2008